| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
326,904 | 301,850 | 274,880 | 261,292 | 293,426 |
| Cost of Revenue
|
-64,235 | -58,339 | -53,252 | -51,710 | -53,884 |
|
Gross Profit
|
262,669 | 243,511 | 221,628 | 209,582 | 239,542 |
| Selling, General and Administrative Expenses
|
-163,175 | -153,122 | -150,792 | -158,645 | -156,319 |
|
Research and Development Expenses
|
-93,894 | -78,981 | -74,723 | -82,617 | -86,562 |
|
Operating Income/Expenses
|
-257,069 | -232,103 | -225,515 | -241,262 | -242,881 |
|
Total Operating Profit/Loss
|
5,600 | 11,408 | -3,887 | -31,680 | -3,339 |
| Total Net Finance Income/Expense
|
20,328 | 21,135 | 17,789 | 13,967 | 6,684 |
| Net Investment Income
|
-3,236 | -3,236 | -1,237 | -40 | 1,368 |
|
Non-Operating Income/Expenses, Total
|
17,092 | 17,899 | 16,552 | 13,927 | 8,052 |
|
Pretax Income
|
22,692 | 29,307 | 12,665 | -17,753 | 4,713 |
|
Provision for Income Tax
|
-9,146 | -9,050 | -6,627 | -3,837 | -4,879 |
|
Net Income from Continuing Operations
|
13,546 | 20,257 | 6,038 | -21,590 | -166 |
|
Discontinued Operations
|
-6,619 | -- | -- | -- | -- |
|
Net Income after Extraordinary Items and Discontinued Operations
|
13,934 | 20,257 | 6,038 | -21,590 | -166 |
|
Net Income after Non-Controlling/Minority Interests
|
13,934 | 20,257 | 6,038 | -21,590 | -166 |
|
Net Income Available to Common Stockholders
|
13,934 | 20,257 | 6,038 | -21,590 | -166 |
|
Diluted Net Income Available to Common Stockholders
|
13,934 | 20,257 | 6,038 | -21,590 | -166 |
| Basic EPS
|
0.32 | 0.47 | 0.14 | -0.50 | 0.00 |
| Diluted EPS
|
0.31 | 0.45 | 0.14 | -0.50 | 0.00 |
|
Basic Weighted Average Shares Outstanding
|
42,265.68 | 42,879.06 | 41,982.85 | 42,871.77 | 44,943.17 |
|
Diluted Weighted Average Shares Outstanding
|
44,190.05 | 44,698.54 | 43,362.91 | 42,871.77 | 44,943.17 |
|
Reported Normalized Diluted EPS
|
1.24 | 1.15 | 0.87 | 0.43 | 0.68 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
2,056 | 7,864 | -5,360 | -31,917 | -2,178 |
|
EBITDA
|
14,177 | 19,548 | 6,476 | -19,673 | 9,514 |
|
Normalized EBITDA
|
53,429 | 47,364 | 34,677 | 17,565 | 37,667 |
|
Normalized Income
|
54,761 | 51,484 | 37,720 | 18,926 | 31,305 |
|
Total Unusual Items
|
29,268 | 24,035 | 26,027 | 34,265 | 27,285 |
|
Total Unusual Items Excluding Goodwill
|
29,268 | 24,035 | 26,027 | 34,265 | 27,285 |
12/31/2022 - 9/30/1999
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade